Showing results (101-110 of 122) with videos related to
Sort By:
Pageof 13
Journal of Virology|June 15, 2007
In vivo and in vitro escape from neutralizing antibodies 2G12, 2F5, and 4E10Amapola Manrique, Peter Rusert, Beda Joos, et al.Molecular Cancer Research : MCR|February 26, 2009
Large-scale production and characterization of novel CD4+ cytotoxic T cells with broad tumor specificity for immunotherapyClaudia Jursik, Michaela Prchal, Regina Grillari-Voglauer, et al.AIDS (London, England)|October 9, 2002
Antiviral activity of the neutralizing antibodies 2F5 and 2G12 in asymptomatic HIV-1-infected humans: a phase I evaluationGabriela Stiegler, Christine Armbruster, Brigitta Vcelar, et al.The Biochemical Journal|January 22, 2005
Interaction of U-box E3 ligase SNEV with PSMB4, the beta7 subunit of the 20 S proteasomeMarlies Löscher, Klaus Fortschegger, Gustav Ritter, et al.Journal of Virology|June 20, 2002
The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120Christopher N Scanlan, Ralph Pantophlet, Mark R Wormald, et al.Nucleic Acids Research|December 8, 2005
SNEV is an evolutionarily conserved splicing factor whose oligomerization is necessary for spliceosome assemblyJohannes Grillari, Paul Ajuh, Guido Stadler, et al.Tissue Engineering. Part A|January 8, 2009
Telomerase immortalized human amnion- and adipose-derived mesenchymal stem cells: maintenance of differentiation and immunomodulatory characteristicsSusanne Wolbank, Guido Stadler, Anja Peterbauer, et al.Journal of Virology|March 3, 2004
The long third complementarity-determining region of the heavy chain is important in the activity of the broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2F5Michael B Zwick, H Kiyomi Komori, Robyn L Stanfield, et al.Journal of Virology|November 16, 2004
Comprehensive cross-clade neutralization analysis of a panel of anti-human immunodeficiency virus type 1 monoclonal antibodiesJames M Binley, Terri Wrin, Bette Korber, et al.The Journal of Infectious Diseases|January 1, 2004
Potent cross-group neutralization of primary human immunodeficiency virus isolates with monoclonal antibodies--implications for acquired immunodeficiency syndrome vaccineFlavia Ferrantelli, Moiz Kitabwalla, Robert A Rasmussen, et al.Pageof 13